Immunohistochemical analysis of FKBP51 in human cancers

Current Opinion in Pharmacology

Volumn 11, Issue 4, 2011, Pages 338-347

  Staibano, Stefania ^a   Mascolo, Massimo ^a   Ilardi, Gennaro ^a   Siano, Maria ^a   De Rosa, Gaetano ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CALCINEURIN; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; FK 506 BINDING PROTEIN 52; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 90; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEPTIDYLPROLYL ISOMERASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESISTANCE; CELLULAR DISTRIBUTION; COLON CANCER; DRUG EFFECT; DRUG SENSITIVITY; ENZYME ACTIVITY; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN MELANOMA; SQUAMOUS CELL CARCINOMA; TETRATRICOPEPTIDE REPEAT; TISSUE DISTRIBUTION;

EID: 80051670905     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.04.001     Document Type: Review

References (58)

1. C.B. Kang, Y. Hong, S. Dhe-Paganon, and H.S. Yoon FKBP family proteins: immunophilins with versatile biological functions Neurosignals 16 2008 318 325
2. G. Baughman, G.J. Wiederrecht, N.F. Campbell, M.M. Martin, and S. Bourgeois FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition Mol Cell Biol 15 1995 4395 4402
3. S. Giraudier, H. Chagraoui, E. Komura, S. Barnache, B. Blanchet, J.P. LeCouedic, D.F. Smith, F. Larbret, A.L. Taksin, and F. Moreau-Gachelin Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors Blood 100 2002 2932 2940
4. O. Bock, M. Neusch, G. Büsche, M. Mengel, and H. Kreipe Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non-neoplastic haematopoiesis Eur J Haematol 72 2004 239 244 (Pubitemid 38406554)
5. W. Jiang, S. Cazacu, C. Xiang, J.C. Zenklusen, H.A. Fine, M. Berens, B. Armstrong, C. Brodie, and T. Mikkelsen FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway Neoplasia 10 2008 235 243 (Pubitemid 351337518)
6. S. Periyasamy, T. Hinds Jr., L. Shemshedini, W. Shou, and E.R. Sanchez FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A Oncogene 29 2010 1691 1701
7. L. Li, Z. Lou, and L. Wang The role of FKBP5 in cancer aetiology and chemoresistance Br J Cancer 104 2011 19 23
8. T. Bouwmeester, A. Bauch, H. Ruffner, P.O. Angrand, G. Bergamini, K. Croughton, C. Cruciat, D. Eberhard, J. Gagneur, and S. Ghidelli A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway Nat Cell Biol 6 2004 97 105 (Pubitemid 38425708)
9. R. Avellino, S. Romano, R. Parasole, R. Bisogni, A. Lamberti, V. Poggi, S. Venuta, and M.F. Romano Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells Blood 106 2005 1400 1406 (Pubitemid 41129607)
10. S. Romano, A. D'Angelillo, R. Pacelli, S. Staibano, E. De Luna, R. Bisogni, E.L. Eskelinen, M. Mascolo, G. Cal, and C. Arra Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells Cell Death Differ 17 2010 145 157
11. A. Loercher, T.L. Lee, J.L. Ricker, A. Howard, J. Geoghegen, Z. Chen, J.B. Sunwoo, R. Sitcheran, E.Y. Chuang, and J.B. Mitchell Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma Cancer Res 64 2004 6511 6523 (Pubitemid 39297908)
12. M.F. Romano, R. Avellino, A. Petrella, R. Bisogni, S. Romano, and S. Venuta Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells Eur J Cancer 40 2004 2829 2836 (Pubitemid 39574738)
13. J. Cheung-Flynn, P.J. Roberts, D.L. Riggs, and D.F. Smith C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90 J Biol Chem 278 2003 17388 17394 (Pubitemid 36799624)
14. T.H. Davies, Y.M. Ning, and E.R. Sánchez A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins J Biol Chem 277 2002 4597 4600 (Pubitemid 34968486)
15. W.B. Denny, V. Prapapanich, D.F. Smith, and J.G. Scammell Structure-function analysis of squirrel monkey FK506-binding protein 51, a potent inhibitor of glucocorticoid receptor activity Endocrinology 146 2005 3194 3201 (Pubitemid 41002828)
16. B. Wu, P. Li, Y. Liu, Z. Lou, Y. Ding, C. Shu, S. Ye, M. Bartlam, B. Shen, and Z. Rao 3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex Proc Natl Acad Sci USA 101 2004 8348 8353 (Pubitemid 38736578)
17. P. Csermely, T. Schnaider, C. Soti, Z. Prohászka, and G. Nardai The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review Pharmacol Ther 79 1998 129 168 (Pubitemid 28380440)
18. Y. Wang, R. Thuillier, and M. Culty Prenatal estrogen exposure differentially affects estrogen receptor-associated proteins in rat testis gonocytes Biol Reprod 71 2004 1652 1664 (Pubitemid 39403262)
19. G.M. Wochnik, J. Rüegg, G.A. Abel, U. Schmidt, F. Holsboer, and T. Rein FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells J Biol Chem 280 2005 4609 4616 (Pubitemid 40288629)
20. W.B. Pratt, and D.O. Toft Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery Exp Biol Med (Maywood) 228 2003 111 133 (Pubitemid 36187918)
21. T. Ratajczak, B.K. Ward, and R.F. Minchin Immunophilin chaperones in steroid receptor signalling Curr Top Med Chem 3 2003 1348 1357
22. M.B. Cox, D.L. Riggs, M. Hessling, F. Schumacher, J. Buchner, and D.F. Smith FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity Mol Endocrinol 21 2007 2956 2967 (Pubitemid 350223507)
23. T.R. Hubler, W.B. Denny, D.L. Valentine, J. Cheung-Flynn, D.F. Smith, and J.G. Scammell The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness Endocrinology 144 2003 2380 2387 (Pubitemid 36629888)
24. H. Vermeer, B.I. Hendriks-Stegeman, B. van der Burg, S.C. van Buul-Offers, and M. Jansen Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability J Clin Endocrinol Metab 88 2003 277 284 (Pubitemid 36115178)
25. A.M. Silverstein, M.D. Galigniana, M.S. Chen, J.K. Owens-Grillo, M. Chinkers, and W.B. Pratt Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin J Biol Chem 272 1997 16224 16230 (Pubitemid 27276441)
26. C.R. Sinars, J. Cheung-Flynn, R.A. Rimerman, J.G. Scammell, D.F. Smith, and J. Clardy Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes Proc Natl Acad Sci USA 100 2003 868 873 (Pubitemid 36183922)
27. P.D. Reynolds, Y. Ruan, D.F. Smith, and J.G. Scammell Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51 J Clin Endocrinol Metab 84 1999 663 669 (Pubitemid 29075703)
28. W.B. Denny, D.L. Valentine, P.D. Reynolds, D.F. Smith, and J.G. Scammell Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding Endocrinology 141 2000 4107 4113
29. D.F. Smith, and D.O. Toft Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions Mol Endocrinol 22 2008 2229 2240
30. H. Pei, L. Li, B.L. Fridley, G.D. Jenkins, K.R. Kalari, W. Lingle, G. Petersen, Z. Lou, and L. Wang FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt Cancer Cell 16 2009 259 266
31. P.D. Reynolds, S.J. Pittler, and J.G. Scammell Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate J Clin Endocrinol Metab 82 1997 465 472 (Pubitemid 27068613)
32. J.G. Scammell, W.B. Denny, D.L. Valentine, and D.F. Smith Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates Gen Comp Endocrinol 124 2001 152 165 (Pubitemid 33065587)
33. J. Botos, W. Xian, D.F. Smith, and C.L. Smith Progesterone receptor deficient in chromatin binding has an altered cellular state J Biol Chem 279 2004 15231 15239 (Pubitemid 38618919)
34. H.A. Kester, B.M. van der Leede, P.T. van der Saag, and B. van der Burg Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation J Biol Chem 272 1997 16637 16643 (Pubitemid 27276496)
35. L.C. Amler, D.B. Agus, C. LeDuc, M.L. Sapinoso, W.D. Fox, S. Kern, D. Lee, V. Wang, M. Leysens, and B. Higgins Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1 Cancer Res 60 2000 6134 6141
36. W. Zhu, J.S. Zhang, and C.Y. Young Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP Carcinogenesis 22 2001 1399 1403 (Pubitemid 32898696)
37. J. Cheung, and D.F. Smith Molecular chaperone interactions with steroid receptors: an update Mol Endocrinol 14 2000 939 946 (Pubitemid 32250512)
38. J.G. Scammell Steroid resistance in the squirrel monkey: an old subject revisited ILAR J 41 2000 19 25
39. X. Zhang, A.F. Clark, and T. Yorio FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness Invest Ophthalmol Vis Sci 49 2008 1037 1047
40. C. Sullivan, and G.C. Chung Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques Clin Colorectal Cancer 7 2008 172 177 (Pubitemid 351758146)
41. L. Luongo de Matos, D.C. Trufelli, M.G. de Matos, and M.A. da Silva Pinhal Immunohistochemistry as an important tool in biomarkers detection and clinical practice Biomark Insights 5 2010 9 20
42. J. Teruya-Feldstein The immunohistochemistry laboratory. Looking at molecules and preparing for tomorrow Arch Pathol Lab Med 134 2010 1659 1665
43. G. Baughman, G.J. Wiederrecht, F. Chang, M.M. Martin, and S. Bourgeois Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition Biochem Biophys Res Commun 232 1997 437 443 (Pubitemid 27216235)
44. S. Romano, A. D'Angelillo, S. Staibano, G. Ilardi, and M.F. Romano FK506-binding protein 51 is a possible novel tumoral marker Cell Death Dis 1 2010 e55
45. S.C. Nair, R.A. Rimerman, E.J. Toran, S. Chen, V. Prapapanich, R.N. Butts, and D.F. Smith Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor Mol Cell Biol 17 1997 594 603 (Pubitemid 27044358)
46. H. Mukaide, Y. Adachi, S. Taketani, M. Iwasaki, N. Koike-Kiriyama, A. Shigematsu, M. Shi, S. Yanai, K. Yoshioka, Y. Kamiyama, and S. Ikehara FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma Cancer Invest 26 2008 385 390 (Pubitemid 351601395)
47. G. Dong, Z. Chen, T. Kato, and C. Van Waes The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma Cancer Res 59 1999 3495 3504 (Pubitemid 29334514)
48. D.C. Duffey, C.V. Crowl-Bancroft, Z. Chen, F.G. Ondrey, M. Nejad-Sattari, G. Dong, and C. Van Waes Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death Br J Cancer 83 2000 1367 1374
49. J.S. Wolf, Z. Chen, G. Dong, J.B. Sunwoo, C.C. Bancroft, D.E. Capo, N.T. Yeh, N. Mukaida, and C. Van Waes IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas Clin Cancer Res 7 2001 1812 1820 (Pubitemid 32708653)
50. P.G. Febbo, M. Lowenberg, A.R. Thorner, M. Brown, M. Loda, and T.R. Golub Androgen mediated regulation and functional implications of FKBP51 expression in prostate cancer J Urol 173 2005 1772 1777 (Pubitemid 40524830)
51. H. Makkonen, M. Kauhanen, V. Paakinaho, T. Jääskeläinen, and J.J. Palvimo Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers Nucleic Acids Res 37 2009 4135 4148
52. T.J. Ahonen, J. Xie, M.J. LeBaron, J. Zhu, M. Nurmi, K. Alanen, H. Rui, and M.T. Nevalainen Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells J Biol Chem 278 2003 17292 27287
53. B. Li, A. Sun, H. Youn, Y. Hong, P.F. Terranova, J.B. Thrasher, P. Xu, and D. Spencer Conditional Akt activation promotes androgen-independent progression of prostate cancer Carcinogenesis 28 2007 572 583 (Pubitemid 46523353)
54. C.D. Chen, and C.L. Sawyers NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer Mol Cell Biol 22 2002 2862 2870 (Pubitemid 34263006)
55. B. Cinar, F. Yeung, H. Konaka, M.W. Mayo, M.R. Freeman, H.E. Zhau, and L.W. Chung Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells Biochem J 379 2004 421 431 (Pubitemid 38570115)
56. S.O. Lee, W. Lou, N. Nadiminty, X. Lin, and A.C. Gao Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells Prostate 64 2005 160 167 (Pubitemid 40791765)
57. J. Trepel, M. Mollapour, G. Giaccone, and L. Neckers Targeting the dynamic HSP90 complex in cancer Nat Rev Cancer 10 2010 537 549
58. P. Brandtzaeg The increasing power of immunohistochemistry and immunocytochemistry J Immunol Methods 216 1998 49 67 (Pubitemid 28440379)